Titan Medical Inc (TMDIF)

[Frankestin]

Our management team is completely aligned with the Board's decision to explore options to maximize shareholder value. We believe it is prudent to undertake a review of our strategic options to determine the best path forward to realize the value of our innovations in single-access robotic-assisted technologies to maximize shareholder value. Our Board and management team remain committed to our strategy of providing patients, surgeons and hospitals with an innovative improved surgical experience.
BOARD TO CONSIDER FULL RANGE OF STRATEGIC ALTERNATIVES INCLUDING CORPORATE SALE, MERGER, OTHER BUSINESS COMBINATION

BOARD WILL CONSIDER SALE OF ALL OR A PORTION OF COMPANY'S ASSETS, STRATEGIC INVESTMENT OR OTHER SIGNIFICANT TRANSACTION

Come on, ISRG, hit it!